Stromectol and Pantoprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Stromectol (ivermectin) and Pantoprazole (pantoprazole sodium). Common drug interactions include diarrhoea among females and coma among males.

The phase IV clinical study analyzes what interactions people have when they take Stromectol and Pantoprazole. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Stromectol?

Stromectol has active ingredients of ivermectin. eHealthMe is studying from 3,361 Stromectol users. Check the latest studies of Stromectol.

What is Pantoprazole?

Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 285,167 Pantoprazole users. Check the latest studies of Pantoprazole.



On Aug, 02, 2026

38 people who take Stromectol and Pantoprazole together, and have interactions are studied.

Stromectol and Pantoprazole drug interactions.

What are the common drug interactions of Stromectol and Pantoprazole, by gender? *:

female:

  1. Diarrhoea
  2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  3. Cheilitis (infection of lips)
  4. Conjunctivitis (pink eye)
  5. Lung disorder (lung disease)
  6. Rash
  7. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  8. Dyspepsia (indigestion)
  9. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  10. Hypertension (high blood pressure)

male:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Hyperammonaemia
  3. Multiple fractures
  4. Nephropathy (damage to or disease of a kidney)
  5. Pain
  6. Renal atrophy (wasting of kidney)
  7. Rib fracture
  8. Poisoning deliberate
  9. Chronic kidney disease
  10. Pemphigoid (tense blisters on the skin)

What are the common drug interactions of Stromectol and Pantoprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Pruritus generalised (generalized itching)
  2. Rash erythematous (redness of the skin)
  3. Chronic kidney disease

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Emotional distress
  4. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  5. Multiple fractures
  6. Nephropathy (damage to or disease of a kidney)
  7. Pain
  8. Renal atrophy (wasting of kidney)
  9. Rib fracture

50-59:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Hyperammonaemia
  3. Poisoning deliberate

60+:

  1. Diarrhoea
  2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  3. Hypertension (high blood pressure)
  4. Hypotension (abnormally low blood pressure)
  5. Platelet count decreased
  6. Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
  7. Accommodation disorder
  8. Anaemia (lack of blood)
  9. Asthenia (weakness)
  10. Blood alkaline phosphatase increased

What are the existing conditions these people have? *

  1. Acarodermatitis (skin inflammation caused by mites (acarids)): 20 people, 52.63%
  2. Type 2 Diabetes: 11 people, 28.95%
  3. Pemphigoid (tense blisters on the skin): 10 people, 26.32%
  4. Gastritis (inflammation of stomach): 10 people, 26.32%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 10 people, 26.32%
  6. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 9 people, 23.68%
  7. Poisoning Deliberate: 8 people, 21.05%
  8. Urinary Tract Infection: 4 people, 10.53%
  9. Infection: 4 people, 10.53%
  10. High Blood Pressure: 4 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Stromectol and Pantoprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Stromectol and Pantoprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Stromectol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pantoprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Stromectol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pantoprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ivermectin and pantoprazole sodium (the active ingredients of Stromectol and Pantoprazole, respectively), and Stromectol and Pantoprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: